MrTimothy Connor

I am a molecular and translational researcher investigating how disruptions in cellular metabolism contribute to chronic disease, impaired physical function, and ageing. Throughout my career, I have focused on understanding the biological mechanisms that underpin metabolic disease and identifying opportunities to translate these discoveries into therapeutic interventions.

My early research centred on the molecular pathways driving diabetes and cardiometabolic disease, contributing to projects that progressed from mechanistic discovery through to preclinical development and, in one case, a diabetes therapy that advanced to Phase II clinical trials. This work established a long-standing interest in how cellular signalling pathways can be manipulated to improve health outcomes.

Over time, my research has expanded to encompass mitochondrial biology, exercise adaptation, and muscle wasting disorders. By combining molecular biology, physiology, and preclinical disease models, I investigate how skeletal muscle and other metabolically important tissues respond to ageing, chronic disease, and therapeutic intervention.

My current work focuses on developing novel small-molecule therapies for muscle wasting and identifying the biological pathways through which exercise exerts its health benefits. These programs aim to uncover new approaches for preserving muscle function, mobility, and metabolic health across a range of chronic and age-related conditions.

The common theme throughout my research has been the translation of mechanistic insight into meaningful health outcomes. Whether investigating diabetes, cardiovascular disease, or muscle wasting, my goal is to generate knowledge that can be developed into practical interventions that improve human health and quality of life.